Sort   by:  
 Page size 
UnknownSARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses.
Not available
S-EPMC8723827 | biostudies-literature
UnknownSARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination.
Not available
S-EPMC9762734 | biostudies-literature
UnknownCo-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.
Not available
S-EPMC8172149 | biostudies-literature
UnknownA randomized trial of therapies for type 2 diabetes and coronary artery disease.
Not available
S-EPMC2863990 | biostudies-literature
UnknownPrevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort.
Not available
S-EPMC2692660 | biostudies-literature
UnknownProphylactic biological mesh reinforcement versus standard closure of stoma site (ROCSS): a multicentre, randomised controlled trial.
Not available
S-EPMC7016509 | biostudies-literature
UnknownTroponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes.
Not available
S-EPMC4627639 | biostudies-literature
UnknownPara-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses.
Not available
S-EPMC10746705 | biostudies-literature
UnknownImportance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England.
Not available
S-EPMC8188158 | biostudies-literature
UnknownClinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study.
Not available
S-EPMC7488201 | biostudies-literature
Sort   by:  
 Page size